ELCELYX THERAPEUTICS, INC.

ACTIVE

10578 Science Center Dr Ste 250, San Diego, California, United Stateswww.elcelyx.comPrivate1–10 employeesEstablished: 2010-01-01

Also known as:

elcelyx

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2010

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

50.0%

Phase 2

50.0%

Trial Status Distribution

Completed

100.0%

Clinical Trials

Trials sponsored by this organization (6)

Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM

Phase 2

Completed

interventional

Sep 2015571 participants

Assessing the Behavior of Met DR in Subjects With Kidney Dysfunction

Phase 2

Completed

interventional

Jan 201439 participants

Assessing the Efficacy, Safety, and Tolerability of Met DR in Subjects With T2DM Over 12 Weeks

Phase 2

Completed

interventional

Apr 2013240 participants

Assessing the Effect of Met DR on Plasma Glucose and PK in Subjects With T2DM

Phase 1

Completed

interventional

Dec 201226 participants

Assessing the PK of Met DR, Met IR, and Met XR in Healthy Subjects

Phase 1

Completed

interventional

Oct 201220 participants

Assessing the PK and Effect on Glucose and GI Hormone Concentrations of Metformin Delayed-Release in Subjects With T2DM

Phase 1

Completed

interventional

May 201224 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations